Literature DB >> 9797485

Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures.

S A Jamal1, W S Browner, D C Bauer, S R Cummings.   

Abstract

Nitric oxide slows bone remodeling and bone loss in animals. Because nitroglycerin and other nitrates increase nitric oxide levels, we hypothesized that nitrate use may be associated with greater bone mineral density (BMD) and decreased risk of fracture in humans. Further, intermittent nitrate use may be associated with greater benefits than daily nitrate use, which results in tachyphylaxis. We tested this hypothesis using data from the Study of Osteoporotic Fractures. We prospectively studied 6201 elderly women of whom 317 took nitrates on a daily basis and 74 used them intermittently. We measured BMD at the hip and the heel and adjusted all comparisons for multiple potential confounders. We found that women taking daily nitrates had slightly greater hip BMD (difference, 13%; 95% confidence interval [CI], 0.14-4.1%) but the same heel BMD (difference, 0%; 95% CI -2.6-2.6%) as nonusers. By contrast, women using nitrates intermittently had substantially greater hip (difference, 2.6%; 95% CI, 0.4-6.8%) and heel BMD (difference, 53%; 95% CI, 2.6-11%) than nonusers. This study suggests that the intermittent administration of nitrates may enhance BMD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797485     DOI: 10.1359/jbmr.1998.13.11.1755

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  36 in total

Review 1.  New targets for intervention in the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

Review 2.  Regulation of skeletal remodeling by biomechanical input.

Authors:  Janet Rubin
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 3.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 4.  The Key Role of the Blood Supply to Bone.

Authors:  Massimo Marenzana; Timothy R Arnett
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

5.  A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.

Authors:  Hema Kalyanaraman; Ghania Ramdani; Jisha Joshua; Nadine Schall; Gerry R Boss; Esther Cory; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  J Bone Miner Res       Date:  2016-09-07       Impact factor: 6.741

6.  The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study.

Authors:  J B Richards; L Joseph; K Schwartzman; N Kreiger; A Tenenhouse; D Goltzman
Journal:  Osteoporos Int       Date:  2006-06-22       Impact factor: 4.507

7.  Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.

Authors:  S A Jamal; D Goltzman; D A Hanley; A Papaioannou; J C Prior; R G Josse
Journal:  Osteoporos Int       Date:  2008-09-18       Impact factor: 4.507

8.  iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats.

Authors:  Bruno S Herrera; Rodrigo Martins-Porto; Aline Maia-Dantas; Paula Campi; Luis C Spolidorio; Soraia K P Costa; Thomas E Van Dyke; Robert Gyurko; Marcelo N Muscara
Journal:  J Periodontol       Date:  2011-03-21       Impact factor: 6.993

Review 9.  Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.

Authors:  Mahua Ghosh; Sumit R Majumdar
Journal:  Endocrine       Date:  2014-02-07       Impact factor: 3.633

10.  Polymorphisms in the endothelial nitric oxide synthase gene and bone density/ultrasound and geometry in humans.

Authors:  K Cho; S Demissie; J Dupuis; L A Cupples; S Kathiresan; T J Beck; D Karasik; D P Kiel
Journal:  Bone       Date:  2007-09-29       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.